IR-Med terminates Chief Development Officer Aharon Binur effective Aug 31, 2025

IR-Med, Inc.

Aharon Binur's termination as CDO is effective August 31, 2025.
Termination is not related to any disagreement with the Company's operations or policies.
No successor has been announced for the Chief Development Officer position.

item 5.02

Source: SEC EDGAR

accession 0001493152-25-011698

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.